Haemoptysis in adults: A 5-year study using the French nationwide hospital administrative database

European Respiratory Journal

Volumn 46, Issue 2, 2015, Pages 503-511

  Abdulmalak, Caroline ^a   Cottenet, Jonathan ^b   Beltramo, Guillaume ^a   Georges, Marjolaine ^a,c   Camus, Philippe ^a,c,d   Bonniaud, Philippe ^a,c,d   Quantin, Catherine ^b,c,d  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d Chu   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; GEOGRAPHIC DISTRIBUTION; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG EDEMA; LUNG EMBOLISM; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEASONAL VARIATION; AGED; ARTIFICIAL EMBOLIZATION; CLINICAL TRIAL; COMPLICATION; FACTUAL DATABASE; HOSPITAL MORTALITY; LENGTH OF STAY; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRONCHIECTASIS; DATABASES, FACTUAL; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEMOPTYSIS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY EDEMA; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84938884197     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00218214     Document Type: Article

References (29)

1. Lee BR, Yu JY, Ban HJ, et al. Analysis of patients with hemoptysis in a tertiary referral hospital. Tuberc Respir Dis 2012; 73: 107-114.
2. Savale L, Parrot A, Khalil A, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med 2007; 175: 1181-1185.
3. Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome - a prospective study in a third-world country. Respir Med 2001; 95: 548-552.
4. Boulay F, Berthier F, Sisteron O, et al. Seasonal variation in cryptogenic and noncryptogenic hemoptysis hospitalizations in France. Chest 2000; 118: 440-444.
5. Hirshberg B, Biran I, Glazer M, et al. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997; 112: 440-444.
6. Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med 1991; 151: 2449-2451.
7. Souders CR, Smith AT. The clinical significance of hemoptysis. N Engl J Med 1952; 247: 790-793.
8. Fidan A, Ozdoʇan S, Oruç O, et al. Hemoptysis: a retrospective analysis of 108 cases. Respir Med 2002; 96: 677-680.
9. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120: 1592-1594.
10. Lorgis L, Cottenet J, Molins G, et al. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation 2013; 127: 1767-1774.
11. Aboa-Eboulé C, Mengue D, Benzenine E, et al. How accurate is the reporting of stroke in hospital discharge data? A pilot validation study using a population-based stroke registry as control. J Neurol 2013; 260: 605-613.
12. Quantin C, Cottenet J, Vuagnat A, et al. Qualité des données périnatales issues du PMSI: comparaison avec l'état civil et l'enqute nationale périnatale 2010 [Quality of perinatal statistics from hospital discharge data: comparison with civil registration and the 2010 National Perinatal Survey]. J Gynecol Obstet Biol Reprod 2014; 43: 680-690.
13. Hanf M, Quantin C, Farrington P, et al. Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization. Vaccine 2013; 31: 5856-5862.
14. Gusmano M, Rodwin V, Weisz D, et al. Comparison of rehospitalization rates in France and the United States. J Health Serv Res Policy 2015; 20: 18-25.
15. Quantin C, Benzenine E, Velten M, et al. Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology. Am J Epidemiol 2013; 178: 1731-1739.
16. Lainay C, Benzenine E, Durier J, et al. Hospitalization within the first year after stroke: the Dijon Stroke Registry. Stroke 2015; 46: 190-196.
17. Pan W-H, Li L-A, Tsai M-J. Temperature extremes and mortality from coronary heart disease and cerebral infarction in elderly Chinese. Lancet 1995; 345: 353-355.
18. Yan YY. The influence of weather on human mortality in Hong Kong. Soc Sci Med 2000; 50: 419-427.
19. Rothwell PM, Wroe SJ, Slattery J, et al. Is stroke incidence related to season or temperature? The Oxfordshire Community Stroke Project. Lancet 1996; 347: 934-936.
20. Lejeune JP, Vinchon M, Amouyel P, et al. Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke 1994; 25: 338-341.
21. Fartoukh M, Khoshnood B, Parrot A, et al. Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration 2012; 83: 106-114.
22. Delage A, Tillie-Leblond I, Cavestri B, et al. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration 2010; 80: 387-392.
23. Douglass BE, Carr DT. Prognosis in idiopathic hemoptysis. J Am Med Assoc 1952; 150: 764-765.
24. Samama MM, Conard J, Lillo-Le Louët A. Accidents hémorragiques des nouveaux anticoagulants oraux et examens de la coagulation [Hemorrhagic accidents of the new oral anticoagulants and coagulation assays]. J Mal Vasc 2013; 38: 259-270.
25. Halperin JL, Hankey GJ, Wojdyla DM, et al. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation 2014; 130: 138-146.
26. Garcia-Olivé I, Sanz-Santos J, Centeno C, et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J Vasc Interv Radiol 2014; 25: 221-228.
27. Chen J, Chen L-A, Liang Z-X, et al. Immediate and long-term results of bronchial artery embolization for hemoptysis due to benign versus malignant pulmonary diseases. Am J Med Sci 2014; 348: 204-209.
28. Virally J, Choudat L, Chebbo M, et al. pidémiologie et délais de prise en charge de 355 patients atteints de cancer bronchique [Epidemiology and delays in the management of 355 patients with lung cancer]. Rev Mal Respir 2006; 23: 43-48.
29. Leveque N, Brouchet L, Lepage B, et al. Analyse des délais de prise en charge des cancers thoraciques: étude prospective [An analysis of delays in the management of thoracic cancers: a prospective study]. Rev Mal Respir 2014; 31: 208-213.